Literature DB >> 24164584

History of myocardial iron loading is a strong risk factor for diabetes mellitus and hypogonadism in adults with β thalassemia major.

Ai Leen Ang1, Ploutarchos Tzoulis, Emma Prescott, Bernard A Davis, Maria Barnard, Farrukh T Shah.   

Abstract

Endocrinopathies are common complications of transfusional hemosiderosis among patients with β thalassemia major (TM). Previous studies had shown associations between some endocrinopathies and iron overload of the myocardium, liver and/or endocrine organs as assessed by MRI techniques. This retrospective analysis of 92 patients with TM (median age 36 yr) from a tertiary adult thalassemia unit in UK aimed to determine independent risk factors associated with endocrinopathies among these patients. Unlike previous studies, longitudinal data on routine measurements of iron load [worst myocardial and liver T2* values since 1999, worst LIC by MRI-R2 since 2008 and average 10-yr serum ferritin (SF)] up to April 2010 together with demographic features and age of initiating chelation were analyzed for associations with endocrinopathies. The most common endocrinopathies in this cohort were hypogonadism (67%) and diabetes mellitus (DM) (41%), and these were independently associated with myocardial T2* <20 ms (P < 0.001 and P = 0.008, respectively) and increased age (P = 0.002 and P = 0.016, respectively). DM and hypogonadism were independently associated with average SF >1250 μg/L (P = 0.003) and >2000 μg/L (P = 0.047), respectively. DM was also associated with initial detection of abnormal myocardial T2* at an older age (30 yr vs. 24 yr, P = 0.039). An abnormal myocardial T2* may therefore portend the development of DM and hypogonadism in patients with TM.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  T2*; diabetes mellitus; hemosiderosis; hypogonadism; thalassemia major

Mesh:

Substances:

Year:  2014        PMID: 24164584     DOI: 10.1111/ejh.12224

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  9 in total

1.  Diabetes Mellitus in Thalassaemia Major Patients: A Report from the Southeast of Iran.

Authors:  Ali Bazi; Javad Sharifi-Rad; Daryoush Rostami; Omolbanin Sargazi-Aval; Amin Safa
Journal:  J Clin Diagn Res       Date:  2017-05-01

2.  Acute cardiac decompensation in a patient with beta-thalassemia and diabetes mellitus following cessation of chelation therapy.

Authors:  Eirini Lioudaki; Martin Whyte
Journal:  Clin Case Rep       Date:  2016-09-12

3.  Glucose Metabolism and Insulin Response to Oral Glucose Tolerance Test (OGTT) in Prepubertal Patients with Transfusion-Dependent β-thalassemia (TDT): A Long-Term Retrospective Analysis.

Authors:  Vincenzo De Sanctis; Ashraf T Soliman; Ploutarchos Tzoulis; Shahina Daar; Salvatore Di Maio; Bernadette Fiscina; Christos Kattamis
Journal:  Mediterr J Hematol Infect Dis       Date:  2021-09-01       Impact factor: 2.576

4.  Screening for glucose dysregulation in β-thalassemia major (β-TM): An update of current evidences and personal experience.

Authors:  Vincenzo De Sanctis; Shahina Daar; Ashraf T Soliman; Ploutarchos Tzoulis; Mehran Karimi; Salvatore Di Maio; Christos Kattamis
Journal:  Acta Biomed       Date:  2022-03-14

5.  Relationship between Serum Ferritin and Outcomes in β-Thalassemia: A Systematic Literature Review.

Authors:  Farrukh Shah; Krystal Huey; Sohan Deshpande; Monica Turner; Madhura Chitnis; Emma Schiller; Aylin Yucel; Luciana Moro Bueno; Esther Natalie Oliva
Journal:  J Clin Med       Date:  2022-07-30       Impact factor: 4.964

6.  Economic evaluation of betibeglogene autotemcel (Beti-cel) gene addition therapy in transfusion-dependent β-thalassemia.

Authors:  Anuraag R Kansal; Odette S Reifsnider; Sarah B Brand; Neil Hawkins; Anna Coughlan; Shujun Li; Lael Cragin; Clark Paramore; Andrew C Dietz; J Jaime Caro
Journal:  J Mark Access Health Policy       Date:  2021-06-07

7.  Anti-Thyroid Peroxidase Antibodies and Male Gender Are Associated with Diabetes Occurrence in Patients with Beta-Thalassemia Major.

Authors:  Giovanni M Pes; Francesco Tolu; Maria P Dore
Journal:  J Diabetes Res       Date:  2016-03-31       Impact factor: 4.011

8.  The Influence of Cardiovascular Risk Factors and Hypogonadism on Cardiac Outcomes in an Aging Population of Beta-Thalassemia Patients.

Authors:  Umberto Barbero; Matteo Ajassa; Carmen Maria Gaglioti; Antonio Piga; Giovanni Battista Ferrero; Filomena Longo
Journal:  J Cardiovasc Dev Dis       Date:  2021-12-21

9.  Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multi-center nation-wide cohort.

Authors:  Maddalena Casale; Gian Luca Forni; Elena Cassinerio; Daniela Pasquali; Raffaella Origa; Marilena Serra; Saveria Campisi; Angelo Peluso; Roberta Renni; Alessandro Cattoni; Elisa De Michele; Massimo Allò; Maurizio Poggi; Francesca Ferrara; Rosanna Di Concilio; Filomena Sportelli; Antonella Quarta; Maria Caterina Putti; Lucia Dora Notarangelo; Antonella Sau; Saverio Ladogana; Immacolata Tartaglione; Stefania Picariello; Alessia Marcon; Patrizia Sturiale; Domenico Roberti; Antonio Ivan Lazzarino; Silverio Perrotta
Journal:  Haematologica       Date:  2022-02-01       Impact factor: 9.941

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.